Gastrointestinal symptoms commonly occur in patients with serious illness and can be
associated with substantial distress, increased health care use, a poorer prognosis, and a …

Antiemetic Neurokinin-1 Receptor Blockers - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us …

背景化疗所致恶心呕吐(CINV) 是肿瘤治疗过程中常见的不良反应之一. 中药穴位贴敷作为中医
特色疗法, 在防治CINV 方面可发挥一定疗效, 研究穴位贴敷预防CINV, 对于提高肿瘤患者化疗 …

Abstract Introduction HTX-019 [CINVANTI®(aprepitant injectable emulsion)] is a neurokinin
1 receptor antagonist (NK-1 RA) approved as a 30-min infusion for preventing acute and …

ABSTRACT Objectives: HTX-019 (Cinvanti®) is a novel injectable emulsion formulation of
the neurokinin 1 receptor antagonist (RA) aprepitant, approved (as 30-min infusion and 2 …

Introduction: Prevention of nausea and vomiting is of paramount importance for ensuring
that patients undergoing anticancer treatments have optimal quality of life. The oral fixed …

Chemotherapy-induced nausea and vomiting (CINV) are common adverse drug reactions
with the use of anticancer drugs. Although there are advances in prophylactic therapy, the …

BACKGROUND: Studies report a wide range of incidence and severity of infusion site
adverse events (ISAEs) following fosaprepitant administration. OBJECTIVES: The purposes …

In response to issues with patient adherence and insurance coverage of the oral
preparation, aprepitant, the authors' National Cancer Institute (NCI) designated …

Background Chemotherapy-induced nausea and vomiting (CINV) is one of the common
adverse reactions in the treatment of tumors. Acupoint application, as a characteristic …